Quality Ohio-based regional bank ($9.5B assets) trading at 12x forward EPS after a 15% post-earnings rally. Q2 2026 delivered adjusted EPS beat ($0.96 vs $0.85 est.), NIM expansion to 4.23%, and 51% provision decline. Fair value ~$44 (base) suggests only 3-8% upside from $41.78; Citizens National merger (closing 2H 2026) offers $0.20 accretion in 2027 but is already partially priced in. Value case rests on stable dividend (4.0% yield), low beta (0.62), and quality earnings — not deep discount.
Implied blended multiple ~12.4x forward P/E consistent with peer median. Cross-check with dividend discount model (Gordon growth: $1.68 dividend / (10% required return − 3% growth) = $24 dividend-only floor). Sensitivity: FV moves ±$3-4 per 1x P/E revision. Analyst consensus $42 (7 analysts, target range $36-46, all updated post July 21 earnings). ⚠️ Not investment advice.
| Component | Assumption | USD/share |
|---|---|---|
| P/E value (60% weight) | FY26E EPS $3.55 × 12.5x peer median forward P/E | +26.63 |
| P/TBV value (40% weight) | TBV $23.56 × 1.65x peer median P/TBV | +15.55 |
| Citizens merger accretion | $0.20 2027E EPS accretion × 12.5x P/E, 60% probability × timing | +1.50 |
| Dividend continuity premium | 4.0% yield vs 3.0% peer median × 2yr present value | +0.72 |
| Merger execution reserve | Integration risk haircut on Citizens accretion (–25%) | −0.40 |
| FV base case | Sum: 26.63 + 15.55 + 1.50 + 0.72 − 0.40 | ≈ $44.00 |
Insider activity: EVP Hugh Donlon sold 500 shares at $39.87 on July 24, 2026 ($19,935 total) — very small transaction, not material and post-earnings run. No material insider sales >$500K in trailing 12 months. Institutional ownership 60.68% (Vanguard 5.8%, UBS, AQR, Jane Street increasing positions in Q1 2026). Beta 0.62 confirms defensive characteristics — well below market beta of 1.0.
| Item | FY2023 | FY2024 | FY2025 | 1H 2026 | Guidance FY2026 |
|---|---|---|---|---|---|
| Revenue ($M) | 428 | 423 | 417 | 241 | ~485 (+16%) |
| Net Income ($M) | 119 | 116 | 106 | 57 | ~125 |
| Diluted EPS ($) | 3.38 | 3.28 | 3.00 | 1.59 | ~3.55 |
| NIM (%) | 4.24 | 4.15 | 4.12 | 4.20 | 4.15-4.25 |
| Efficiency ratio (%) | 57.8 | 58.4 | 58.9 | 58.5 | ~58 |
| Loans HFI ($B) | 5.8 | 6.0 | 6.2 | 6.3 | 3-5% loan growth |
| Total assets ($B) | 9.1 | 9.3 | 9.4 | 9.5 | ~10.2 (post-Citizens) |
| Dividend/share ($) | 1.58 | 1.62 | 1.66 | 0.84 | 1.68 |
| Metric | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|
| Revenue ($M) | 108.5 | 105.2 | 108.8 | 119.3 | 121.95 |
| Adj EPS ($) | 0.68 | 0.72 | 0.75 | 0.81 | 0.96 |
| Net income ($M) | 24.1 | 25.5 | 26.4 | 29.0 | 28.0 |
| NIM (%) | 4.10 | 4.12 | 4.12 | 4.16 | 4.23 |
| Efficiency (%) | 59.5 | 58.8 | 58.6 | 58.6 | 58.3 |
| NCO rate (bps) | 52 | 48 | 42 | 38 | 31 |
Business model — Ohio-based community banking with fee income diversification
Commercial Banking ~$260-280M FY26E (55% rev) 🟢 growing C&I and CRE lending to Midwest SMBs; loan book $3.4B, growing 3-5% annually. Underwriting discipline evident in NCO rate declining from 52 to 31 bps over 5 quarters. CRE concentration ~12% of loans (moderate). Retail Banking ~$140-155M FY26E (30% rev) 🟢 stable 130+ branches across 6 states; consumer deposits, mortgages, and home equity. Deposit franchise sticky (~4% annual attrition) — key competitive moat funding low-cost NIM. Fee Income (Insurance + Wealth) ~$85-100M FY26E (20% rev) 🟢 differentiating Peoples Insurance (P&C, life, benefits) and Peoples Wealth Management ($4B+ AUM). Non-interest income mix of ~25% is well above peer average of 18-20%, reducing NIM sensitivity.
Legal, regulatory and risk analysis
SWOT analysis
- +Superior NIM 4.23% vs peer avg 3.70% (+50-60bps advantage sustained across cycles)
- +Diversified fee income (25% of revenue) — insurance + wealth management reduce rate sensitivity
- +Strong capital (CET1 12.66%) and rising TBV per share ($23.56, +45% since 2022)
- +12 consecutive years of dividend growth; 4.0% yield with 50% payout ratio
- +Improving credit trend: NCO rate 52→31 bps over 5 quarters, provision –51% in Q2 2026
- −Post-earnings rally has closed most of the valuation gap; upside limited to ~5-8%
- −Asset-sensitive balance sheet vulnerable to aggressive Fed easing
- −Modest organic growth (3-5% loan growth) — M&A is the primary growth engine
- −Regional concentration (Ohio/W.Virginia/Kentucky) exposes to Midwest economic cycles
- →Citizens National merger closes 2H 2026 → $0.20 EPS accretion in 2027, TBV earnback <1 year
- →40% cost savings on Citizens integration if executed → potential further upside to consensus
- →Continued small-cap rotation trade: Russell 2000 +19% YTD outpacing S&P 500 (+8.7%)
- →Additional M&A firepower in fragmented Midwest community banking market
- !CRE credit cycle deterioration (12% loan concentration) — Midwest office/multifamily most exposed
- !Fed easing cycle (2-3 cuts) could compress NIM to 3.90-4.00% and reduce FY27 EPS $0.15-0.25
- !Regional bank multiple compression if broader sector concerns resurface (SVB-style)
- !Piper Sandler and DA Davidson already at $46 and $44 targets — limited catalyst for further upgrades
Summary by assessment area
- CET1 12.66%, well capitalized
- TBV per share +45% since 2022
- Dividend cover 2x, 50% payout
- No going concern issues
- Modest organic growth (3-5%)
- Citizens integration execution risk
- Regional concentration Midwest
- NIM vulnerable to Fed cuts
- Post +15% rally, FV gap only 5%
- Trades at peer median multiples
- Analyst targets clustered $42-46
- Downside 15-18% to bear case
Sources: Peoples Bancorp Q2 2026 earnings release (July 21, 2026), Q2 2026 investor slides, SEC filings (Form 8-K, S-4/A for Citizens deal), Piper Sandler research (July 22, 2026), DA Davidson research (July 22, 2026), Keefe Bruyette Woods (July 22, 2026), Marketbeat, StockAnalysis.com, Simply Wall St, The Markets Daily (July 28, 2026), Daily Political (July 28, 2026). Market data — last verified close 2026-07-28: PEBO ~$41.78 (T-1, intraday reference from TheMarketsDaily.com and DailyPolitical.com articles published July 28, 2026), market cap ~$1.50B, 52W range $27.49-$41.90, 35.25M shares outstanding. Short interest ~2.8%. Q2 2026 diluted EPS $0.78 reported / $0.96 adjusted; NIM 4.23%; CET1 12.66%; TBV/share $23.56; ROE 10.79%. This document is for informational purposes only and does not constitute financial or investment advice.